News Release

Prof. Annamaria Iagnocco elected to Board of Biomedical Alliance Europe

EULAR celebrates the election of Prof. Annamaria Iagnocco, EULAR Past-President, to the Board of the BioMedical Alliance as of January 2025

Business Announcement

European Alliance of Associations for Rheumatology (EULAR)

Zurich, Switzerland - EULAR ( European Alliance of Associations for Rheumatology)  proudly announces that Prof. Annamaria Iagnocco, has been elected to the board of BioMedical Alliance in Europe as of January 2025, for a term of three years.

BioMedical Alliance in Europe is an organisation that brings together medical societies to promote the interests of biomedical research and healthcare innovation in Europe. The organisation plays a crucial role in shaping policies that support biomedical research and ensure that patients have access to the latest treatments and technologies.

Prof. Annamaria Iagnocco is an internationally recognised and a highly respected rheumatologist and researcher, known for her significant contributions to the field of rheumatology. With her vast experience and expertise, particularly in medical education as the Chair of the BioMed Education Committee, she will be a valuable addition to the board of BioMedical Alliance.

In response to her election, Prof. Iagnocco expressed her gratitude for the opportunity and reaffirmed her commitment to advancing biomedical research and healthcare innovation in Europe. She highlighted the importance of collaboration between medical societies and driving progress in healthcare at the European level.

EULAR extends its heartfelt congratulations to Prof. Iagnocco on her election to the board of BioMedical Alliance and is confident that her achievements will continue to reflect EULAR’s values  and make a positive impact in her new role.

About EULAR

EULAR is the European umbrella organisation representing scientific societies, health professional associations and organisations for people with rheumatic and musculoskeletal diseases (RMDs). EULAR aims to reduce the impact of RMDs on individuals and society, as well as improve RMD treatments, prevention, and rehabilitation. To this end, EULAR fosters excellence in rheumatology education and research, promotes the translation of research advances into daily care, and advocates for the recognition of the needs of those living with RMDs by EU institutions.

Contact

EULAR Communications, communications@eular.org

 

Notes to Editors

EULAR Recommendations

EULAR School of Rheumatology

EULAR Press Releases


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.